Technical Analysis for SNPHF - Santen Pharmaceutica

Grade Last Price % Change Price Change
grade B 17.25 2.68% 0.4500
SNPHF closed up 2.68 percent on Monday, October 28, 2019, on 4 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
See historical SNPHF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Overbought Strength 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Narrow Range Bar Range Contraction 2.68%
Gapped Down Weakness 2.68%
Narrow Range Bar Range Contraction -3.09%
Gapped Up Strength -3.09%
Up 3 Days in a Row Strength -3.09%
Crossed Above 20 DMA Bullish 4.42%
Older signals for SNPHF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Santen Pharmaceutical Co., Ltd. researches and develops, produces, and markets pharmaceuticals and medical devices in Japan and internationally. It offers prescription pharmaceutical products for glaucoma and ocular hypertension, dry eyes, allergic conjunctivitis, severe keratitis with dry eyes, vernal keratoconjunctivitis, uveitis, wet age-related macular degeneration, and myopia; and over-the-counter pharmaceutical products. The company was formerly known as Santendo Pharmaceutical Co., Ltd. and changed its name to Santen Pharmaceutical Co., Ltd. in 1958. Santen Pharmaceutical Co., Ltd. was founded in 1890 and is headquartered in Osaka, Japan.
Medicine Health Medical Specialties RTT Glaucoma Over The Counter Pharmaceutical Products Wet Age Related Macular Degeneration Allergic Conjunctivitis Conjunctivitis Ocular Hypertension Uveitis Prescription Pharmaceutical Products Markets Pharmaceuticals Myopia Pharmaceuticals And Medical Devices Keratoconjunctivitis Santen Pharmaceutical Severe Keratitis Vernal Keratoconjunctivitis

Is SNPHF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 18.1
52 Week Low 13.25
Average Volume 2,316
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 16.0798
10-Day Moving Average 15.8036
Average True Range 0.5672
ADX 16.81
+DI 59.9522
-DI 39.8250
Chandelier Exit (Long, 3 ATRs ) 16.3984
Chandelier Exit (Short, 3 ATRs ) 16.4016
Upper Bollinger Band 18.2134
Lower Bollinger Band 13.9462
Percent B (%b) 0.77
BandWidth 26.5376
MACD Line 0.4110
MACD Signal Line 0.2686
MACD Histogram 0.1424
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.2500
Resistance 3 (R3) 17.2500 17.2500 17.2500
Resistance 2 (R2) 17.2500 17.2500 17.2500 17.2500
Resistance 1 (R1) 17.2500 17.2500 17.2500 17.2500 17.2500
Pivot Point 17.2500 17.2500 17.2500 17.2500 17.2500
Support 1 (S1) 17.2500 17.2500 17.2500 17.2500 17.2500
Support 2 (S2) 17.2500 17.2500 17.2500 17.2500
Support 3 (S3) 17.2500 17.2500 17.2500
Support 4 (S4) 17.2500